It means each ingredient can be traced from its original source through its use in the final formula.

Sourcing information is documented, including origin and handling, and ingredients are selected based on established functional roles rather than availability or labeling considerations.

This approach allows ingredient quality and relevance to be evaluated using objective criteria, and ensures that formulation decisions are supported by identifiable data rather than assumptions.

Ingredient disclosure requirements vary across the pet supplement industry, and many products meet only the minimum standards for labeling.

This level of transparency goes beyond basic disclosure by providing sourcing context and formulation rationale, allowing ingredients to be evaluated not only by name, but by origin and purpose within the formula.

These products are manufactured in facilities that follow current Good Manufacturing Practices (cGMPs), and are produced in accordance with applicable regulatory and quality guidelines.

Compliance focuses on manufacturing controls, documentation, and product testing rather than pre-market approval.

By law, the FDA does not approve pet supplements.

Yes. Because natural ingredients are used, raw materials are subject to strict contaminant screening prior to formulation, including testing for heavy metals.

Testing is conducted at the ingredient level to account for variability that can occur in naturally sourced materials.

For omega-3 ingredients, fish species with shorter lifespans are selected. Short-lived fish are less likely to accumulate heavy metals over time, compared to larger, longer-lived species. This selection criterion is part of the broader approach to managing contaminant risk before ingredients are incorporated into the final formula.